Shifting Paradigms: Biomarker Testing and ESR1 Mutation Surveillance in HR+ HER2- Breast Cancer Dr Ali on the Need for Novel Targets Beyond BCMA in Multiple Myeloma Dr Awan on the Impact of CAR T-Cell Therapy on the CLL Treatment Paradigm ...
PERITONEAL cancerCANCER treatmentCANCER chemotherapyMETASTASISCYTOREDUCTIVE surgeryPeritoneal metastasis is a common finding in patients with advanced gastric cancer. Beyond systemic chemotherapy, additive local treatments such as cytoreductive surgery and intraperitoneal chemotherapy are considered ...
The sixth edition of the Japanese Gastric Cancer Treatment Guidelines was completed in July 2021, incorporating new evidence that emerged after publication
Bilici A. Treatment options in patients with met- astatic gastric cancer: current status and fu- ture perspectives. World J Gastroenterol 2014; 20: 3905-3915.Bilici A. Treatment options in patients with metastatic ga- stric cancer: current status and future perspectives. World J Gastroenterol ...
Expanding treatment options for metastatic gastric cancer2020-05-30作者:医医不舍资讯 200 评论 热门资讯抑制胃酸分泌药——奥美拉唑 胰腺胰岛素瘤的超声内镜下诊断和治疗 食管癌高危人群及筛查、预防策略 临床病例思考:急性出血性直肠溃疡综合征 【会议预告】银屑病新型靶向口服治疗和临床规范交流会(北京场)...
The symptoms of gastric cancer are frequently vague and non-specific All suspected cases should undergo urgent OGD, and staging of gastric cancers should be done via CT chest-abdomen-pelvis and staging laparoscopy Curative treatment options for gastric cancers include total or subtotal gastrectomy with...
The systemic treatment options for advanced gastric cancer (GC) have evolved rapidly in recent years. We have reviewed the recent data of clinical trial incorporating targeted agents, including inhibitors of angiogenesis, human epidermal growth factor receptor 2 (HER2), mesenchymal–epithelial transition...
The systemic treatment options for advanced gastric cancer (GC) have evolved rapidly in recent years. We have reviewed the recent data of clinical trial incorporating targeted agents, including inhibitors of angiogenesis, human epidermal growth factor receptor 2 (HER2), mesenchymal–epithelial transition...
Surgery may be a treatment option for gastric cancer depending on where the cancer is, the stage of the tumor, and the overall health of the patient. The tumor will be removed and all or part of the stomach may be removed as well. The surgeon will remove lymph nodes to see if they ...
gastric cancer. Patients with gastric cancer may suffer sarcopenia no matter before or after surgery, and the pathogenesis is complex. Abnormal nutrient metabolism and reduced exercise are the leading causes. In addition, surgical treatment and chemotherapy for gastric cancer might participate in the ...